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Abstract
Background: The first pillar of the UNAIDS 90-90-90 goal seeks to accurately identify persons living with HIV (PLHIV), a 
process that is predicated on facilities having the necessary HIV tests available to perform the task. In many rural settings, 
the identification of PLHIV is accomplished through a two-step process involving the sequential use of 2 separate rapid 
diagnostic tests (RDTs). Inadequate inventory of either test has ramifications for the success of HIV-related programs. The 
purpose of this study was to evaluate the inventory levels of HIV RDT kits at specific healthcare facilities in Zambézia 
province, Mozambique.
Methods: Using facility-level pharmacy stock surveillance data from October 2015 through September 2016, we assessed 
the inventory levels of HIV RDTs at 75 health facilities in 8 districts within Zambézia province, Mozambique. Using 
programmatically established categories (good, sufficient, threatened, or stockout), defined in conjunction with the 
provincial health authorities, descriptive statistics were performed to determine inventory control of HIV RDTs at the district 
and health facility levels. Monthly proportions of adequate (good + sufficient) inventory were calculated for each district to 
identify inventory trends over the evaluation period. To assess whether the proportion of inadequate stocks differed between 
RDT, a mixed-effects logistic regression was conducted, with inadequate inventory status as the outcome of interest.
Results: When viewed as a whole, the inventory of each test kit was reported as being at adequate levels more than 89% of 
the time across the 75 facilities. However, disaggregated analysis revealed significant variability in the inventory levels of HIV 
RDTs at the district level. Specifically, the districts of Inhassunge, Namacurra, and Pebane reported inadequate inventory 
levels (threatened + stockout), of one or both test kits, for more than 10% of the study period. In addition, a disparity between 
inventory levels of each test kit was identified, with the odds of reporting inadequate inventory levels of the confirmatory test 
(Uni-Gold™) being approximately 1.8-fold greater than the initial test (Determine™) (odds ratio: 1.82, 95% CI: 1.40-2.38). 
Conclusion: As Test and Treat programs evolve, a significant emphasis should be placed on the “test” component of the 
strategy, beginning with assurances that health facilities have the adequate inventory of RDT necessary to meet the needs 
of their community. As national policy-makers rely predominantly on data from the upstream arm of the supply chain, it 
is unlikely the disparity between inventory levels of HIV RDTs identified at individual districts and specific health facilities 
would have been recognized. Moving forward, our findings point to a need for (1) renewed efforts reinforcing appropriate 
downstream forecasting of essential medicines and diagnostic tests in general and for Uni-Gold™ test kits specifically, and (2) 
simple metrics that may be routinely collected at all health facilities and which may then easily and quickly flow upstream so 
that policy-makers may optimally allocate resources. 
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Implications for policy makers
• An assessment of HIV rapid diagnostic test (RDT) inventories in Zambézia province, Mozambique was conducted revealing a disparity in 
inventory levels between the initial and confirmatory tests at the district and facility levels, a finding that would have been lost if based upon 
routine reporting standards which emphasize only composite reporting of provincial level stocks. 
• As demand for HIV testing increases, continued disparities in HIV RDT stocks threaten to undermine Mozambique’s feasibility to meet the first 
90 of the UNAIDS 90-90-90 initiative, that of having 90% of HIV positive persons knowing their HIV status.
Implications for the public
Our assessment of rapid diagnostic tests (RDTs) in Zambézia province, Mozambique revealed a disparity in the inventory levels of initial and 
confirmatory HIV RDTs, a finding that has implications for patient outcomes and on the success of initiatives seeking to end the HIV/AIDS epidemic. 
Inconsistencies in HIV RDT stocks at health facilities could lead to growing frustration among the communities served if individuals are unable to 
receive HIV testing on the day they arrive at the facility for an HIV test, potentially compounding poor trust in the facility as a resource and lowering 
health service access and demand.
Key Messages 
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Background
Diagnostic testing is a cornerstone of public health efforts 
to detect infection and acts as the fundamental precursor 
to prevention, treatment, and disease management. The 
significance of diagnostic testing has been underscored by 
the Sustainable Development Goal of ending the HIV/AIDS 
epidemic by 2030.1,2 Efforts to achieve this goal are embodied 
by programs such as the World Health Organization’s “Test-
and-Treat” strategy, which advocates for all individuals who 
test positive for HIV being placed on life-long combination 
antiretroviral therapy (ART), regardless of their CD4+ cell 
count.3,4 This proactive approach has been endorsed by the 
UNAIDS’ 90-90-90 initiative.5 In an effort to reduce HIV to 
a low-level endemic disease, the 90-90-90 strategy seeks to 
have 90% of persons living with HIV (PLHIV) aware of their 
status by 2020; 90% of all individuals diagnosed with HIV 
placed on sustained ART; and 90% of individuals who have 
initiated ART achieving virologic suppression.5,6 The success, 
or failure, of these ambitious programs rests upon the vast 
majority of PLHIV knowing their status, a pursuit which is 
incumbent upon accurate diagnostic testing. 
The number of PLHIV continues to grow, increasing from 
36.7 million in 2015 to 36.9 million in 2017; however, of those 
infected, it has been estimated that 25%-33% remain unaware 
of their HIV status.5-8 To address this gap and achieve the goal 
of 90% of PLHIV knowing their status, HIV testing must be 
scaled-up to unprecedented levels.6,9 Rapid diagnostic tests 
(RDTs) for HIV play an instrumental role in this process, 
providing a low-cost approach to HIV screening without 
the need for laboratory-based equipment or highly trained 
technicians. Additionally, HIV RDTs have the benefit of 
providing results within 30 minutes, thereby allowing for 
testing, counseling, and referral to take place during a single 
visit.10,11
Ensuring a consistent and continuous flow of HIV RDTs, 
in appropriate quantities, at all points along the supply 
chain, is a complex process requiring a combination of 
accurate forecasting, procurement, and adequate in-country 
transportation and delivery services.12-14 Managing an 
adequate supply of HIV RDTs is further complicated by 
HIV screening algorithms. Unlike RDTs used to detect other 
medical conditions such as malaria, the algorithm for HIV 
testing requires the sequential use of 2 separate RDTs.10 When 
an individual is screened for HIV and the initial test results 
are negative, no further testing is necessary at that time. 
However, if the test results are positive, a second confirmatory 
test is required. This second test is performed using a different 
type of HIV RDT with a greater specificity.15 In cases where 
the initial test is positive and the confirmatory test is negative, 
protocols often dictate that the 2 RDT algorithm be repeated. 
Should the two-test algorithm remain indeterminant after 
repeat testing, patients are asked to come back 3-4 weeks later 
to repeat the testing algorithm.15,16
The absence of either RDT used in this testing sequence 
may result in missed opportunities to adequately capture the 
HIV status of at-risk persons and potentially delay the timely 
initiation of ART. While the stockout of either HIV RDT is a 
signal that the supply chain is failing, insufficient inventory 
levels should also be seen as an important indicator of a 
potentially fragile system. 
Setting 
Located in north-central Mozambique, Zambézia province 
is an extremely poor region of Mozambique, estimated to be 
home to 5 million residents in 2017.17-19 A predominantly rural 
province with limited infrastructure, Zambézia was estimated 
to have an HIV prevalence of 15.1% among adults 15-49 years 
of age in 2015.20 As of 2016, Mozambique’s progress towards 
the 90-90-90 targets showed that 61% of its national HIV 
population had been diagnosed with HIV and of those 54% 
were receiving ART.21,22
HIV Rapid Test Kit Supply Chain in Mozambique
HIV RDTs nationally approved for use in Mozambique 
consist of the Abbott Determine™ HIV 1/2 for initial testing 
and the Trinity Biotech Uni-Gold™ Recombigen® HIV test 
for confirmatory testing. This initial and confirmatory testing 
algorithm is used as point-of-care testing at health facilities 
within their laboratories and when appropriate by providers 
at service delivery points. In addition, this algorithm is 
used within voluntary counseling and testing centers, at the 
community level for community HIV testing campaigns, and 
to test health facility blood supplies. Beyond HIV RDT, the 
only other method used in country for HIV diagnosis is by 
polymerase chain reaction in children less than nine-months 
of age, as part of the Early Infant Diagnosis strategies. 
The supply chain system for HIV RDTs in Mozambique 
begins with the Central Drugs and Medical Supplies 
Procurement (CMAM) service, which is responsible 
for national demand planning, procurement, and initial 
warehousing of all essential health products for the national 
health system.23 All purchased HIV RDTs arrive in Maputo 
(the nation’s capital) via cargo ship and are warehoused at 
the CMAM central warehouse in Zimpeto. From the CMAM 
warehouse, HIV RDTs are then distributed to each of the ten 
provincial warehouses, either by air freight or by truck, on a 
monthly basis (Figure 1).24 Once commodities arrive at the 
provincial warehouses, Mozambique’s supply chain becomes 
decentralized with the responsibility for management and 
distribution of commodities shifting further downstream 
to each Provincial Health Directorate (Direcção Provincial 
de Saúde, DPS) and their respective provincial pharmacy 
warehouses. From these provincial warehouses, commodities 
are pushed out to their respective district warehouses which 
then allocate supply to individual health facilities through a 
push-pull strategy.25 Unlike the distribution of commodities 
upstream, the process of distributing commodities 
downstream is typically accomplished through a series of 
diverse, often irregular, transport options.
Protocol dictates that health facilities have a one-month 
buffer of inventory for HIV RDTs at all times. To calculate the 
quantity of inventory to be requested, monthly consumption 
is multiplied by 2, and inventory on hand is subtracted from 
this amount.26 Assuming that sufficient inventory is available 
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upstream, the quantity of test kits distributed to each health 
facility is based upon monthly consumption reports and 
inventory data that health facilities provide to their district 
warehouse. The quantity of test kits allocated to a district-
level warehouse is, in turn, based upon the reports the district 
provides to the provincial warehouse. This process continues 
upstream, ultimately guiding the quantity of test kits ordered 
by CMAM.26
Technical Support and Monitoring of District Health Facility 
Pharmacies
Friends in Global Health, a Mozambican-registered non-
governmental organization, affiliated with the Vanderbilt 
Institute for Global Health has been working in Zambézia 
province since 2007. As part of its current activities, a 
multidisciplinary team of technical advisors from Friends 
in Global Health provides support and mentoring to a large 
number of health facilities across multiple districts within 
Zambézia province (n = 115 in 12 districts during the study 
period). These 12 districts have a high disparity of reported 
HIV prevalence, with variation in positive testing rates 
reported in routine programmatic data depending on the 
context in which HIV testing occurred. 
Visiting each health facility once a month, on average, 
technical assistance related to managing stocks of HIV 
RDTs includes warehouse and/or pharmacy supply room 
organization, planning and coordination of supply chain 
logistics with health facilities, documentation of quality 
measures related to stock utilization, and the timely and 
appropriate completion of requisitions. This level of individual 
health facility focused technical support is not part of routine 
activities for all health facilities nationwide.
While visiting health facilities, mentoring teams conduct 
exercises to verify records, documenting the available stock at 
each health facility through the counting of physical inventory. 
On weeks when the multidisciplinary mentorship team was 
not present at a particular site, health facility pharmacists 
are contacted by phone to verify that the information in the 
mentoring team’s tracking spreadsheet reflect the stock levels 
reported by the on-site pharmacist for that week. 
In 2008, the international community launched a rallying 
cry to “Know your epidemic, Know your response,” calling 
on program implementers to move away from standard 
approaches and to adapt their programs to individual 
community or health facility needs.27 To date, few studies have 
evaluated HIV RDT stock trends in Mozambique, particularly 
within the more downstream segments of the supply chain. 
The objective of this study was to “Know our epidemic” by 
describing trends over time in HIV RDT inventories at select 
health facilities in Zambézia province, Mozambique, with the 
aim of identifying patterns of threatened inventory levels and/
or stockouts of the RDTs. By identifying these patterns further 
downstream in the supply chain, we sought to aid national 
policy-makers’ efforts to optimize resources as they strive to 
meet Mozambique’s 90-90-90 targets by 2020.
Methods 
Data Collection
Mirroring the timeline employed by provincial health 
authorities to report on HIV data to the Ministry of Health 
and to programs such as PEPFAR, a serial cross-sectional 
study was conducted with the intent of assessing the 
availability of Determine™ and Uni-Gold™ test kits from 
October 2015 through September 2016 using pharmacy stock 
surveillance records from 75 supported health facilities in 8 
districts within Zambézia province. 
Pharmacy stock surveillance records track the categorical 
status of essential medications and test kits by placing 
each commodity into one of 4 programmatically defined 
categories: good, sufficient, threatened, or stockout. The 
category of “good,” indicated that inventory levels of a specific 
commodity not only met the forecasted need for the week but 
also maintained the recommended 1-month buffer for that 
product. A “sufficient” status indicated that a health facility had 
the necessary inventory on hand to meet the forecasted need 
for that week, however the 1-month additional supply was not 
maintained. A commodity was categorized as “threatened” if 
a supply of the commodity existed but the inventory on hand 
had fallen below the forecasted need for the week. Finally, the 
category “stockout” indicated that the product was completely 
Figure 1. Distribution of HIV RDT Kits in Mozambique. Abbreviations: CMAM, Central Drugs and Medical Supplies Procurement; RDT, rapid diagnostic test.
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unavailable. These categories were visually expressed within 
the stock surveillance tracking sheets as a 4 color “heat map” 
with “good” shown in green, “sufficient” shown in yellow, 
“threatened” in red, and “stockout” in black (Figure 2).
As part of the data cleaning process, the decision was made 
to exclude health facilities from the study if reportable data 
were missing for more than 6 consecutive weeks. After taking 
this step, the tracking spreadsheets from the remaining health 
facilities were consistently missing data for one or more weeks 
in December. Therefore, the entire month of December was 
removed from the sample. After exclusion, the final study 
sample consisted of 11 months of data for 75 supported 
facilities across 8 districts. For this remaining sample, 
unreported data was a rarity, accounting for less than 1% of 
the study period. Prior to analysis, data from the original 
Excel spreadsheets were selected at random and compared 
to the data imported into STATA to ensure no errors were 
introduced. 
Data Analysis
Descriptive statistics were performed to determine inventory 
status (good, sufficient, threatened, stockout) for the overall 
sample, as well as at the district and facility levels. For the 
purposes of this evaluation we defined “adequate stock” 
by combining the categories of good and sufficient stock 
levels. Similarly, the combination of threatened and stockout 
inventory levels were used to define the category “inadequate 
stock.” Inventory levels of Determine™ and Uni-Gold™ 
test kits were assessed separately. As no prior measure for 
assessing inventory levels of categorical data existed, we chose 
an inadequate stock threshold of 10% to identify districts and 
individual health facilities of concern. 
To assess patterns of inventory status at the district level 
over time, weekly facility-level data were collapsed into 
dichotomous categories for each month. The number of 
health facilities within each district identified as being 
inadequate were counted and the monthly counts were 
divided by the total number of facilities within the district 
to create the proportion of facilities within the district that 
experienced inadequate inventory levels each month. To 
assess whether the proportion of inadequate stocks differed 
between Determine™ and Uni-Gold™ kits, while accounting 
for the nested structure of the data, a mixed-effects logistic 
regression was conducted, with inadequate inventory status 
as the outcome of interest. Covariates included type of test kit 
and time (month) with random effects for district and health 
facility. STATA 14 was used to conduct all statistical analysis.
Results
Overall Sample
During the 44-week period that inventory levels of 
Determine™ and Uni-Gold™ test kits were tracked, a total of 
3277 weekly inventory observations were reviewed. 
When examining the study sample as a whole, inventory 
levels of Determine™ test kits were reported as being at 
adequate levels (good + sufficient) more than 90% of the 
time. Threatened inventories of Determine™ RDTs were 
reported 5% of the time, with instances of stockouts reported 
only 4 times (0.1%) across all 8 districts over the study 
period, suggesting a high level of commodity security for 
Determine™ RDTs across the sample (Table 1). However, 
an examination of Uni-Gold™ RDT inventory revealed 
a much higher frequency of inadequate stock, with levels 
reaching 10.3% (threatened stock (7.6%) and stockout (2.7%), 
respectively), for the confirmatory RDT.
District Level 
The 4 reported stockouts of the Determine™ RDT occurred 
in 3 supported districts; namely, Morrumbala (n = 1), 
Inhassunge (n= 1), and Namacurra (n = 2). However, all 8 
districts reported experiencing threatened inventory levels 
of the Determine™ test kit at some point during the study 
period, with threats occurring 1.3% to 7.7% of the time. 
Despite these threats, no individual district exceeded the 10% 
threshold for inadequate inventories of Determine™.
In contrast, stockouts of the Uni-Gold™ RDT were 
widespread, with 7 of the supported 8 districts reporting 
stockouts during the study period. The district of Gilé was 
a notable exception, with no reported stockouts of either 
test kit. Similar to inventory levels of the Determine™ RDT, 
all 8 districts reported threatened levels of Uni-Gold™ at 
some point during the study period. In turn, the frequency 
of districts reporting threatened inventory levels were 
comparatively higher for Uni-Gold™, occurring between 
3.0% and 30.5% of the time. Three supported districts were 
identified as exceeding the 10% threshold of concern for 
inadequate inventory levels of Uni-Gold™: Namacurra 
(12.1%), Pebane (19.6%) and Inhassunge (45.5%). 
The district of Inhassunge stood out as being of particular 
concern, reporting good inventory levels of Uni-Gold™ 
Figure 2. Illustrative Heat Map of HIV RDT Kit Commodities. Data comes from one health facility illustrating the tracking sheets used at all data collection sites involved 
in this study.  Abbreviation: RDT, rapid diagnostic test.
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merely 6.8% of the time and sufficient levels of stock only 
47.7% of the time. In other words, inventory levels of Uni-
Gold™ were reported as being adequately stocked for just 
over half of the study period (54.5%). Maintenance of the 
prescribed 1-month buffer of RDTs in Inhassunge was also 
noted as a challenge for Determine™ RDTs with good levels 
of the RDT reported less than 8% of the time. However, 
sufficient inventory levels were reported 84.6% of the time.
Health Facility Level
The frequency of inventory status was examined further 
downstream, at the health facility level, to assess variability 
across facilities within each of the 8 supported districts. 
Although district level assessments did not reveal inadequate 
inventory levels of Determine™ breaching our predefined 10% 
threshold, facility level assessments revealed 11 health facilities 
reporting inadequate inventory levels of Determine™ that 
exceeded the threshold. These health facilities were located 
within the districts of Alto Molocue (n = 4), Inhassunge 
(n = 2), and Morrumbala (n = 5), (Supplementary file 1). 
Assessment of Uni-Gold™ inventories revealed a more 
widespread occurrence of inadequate inventory levels in 
excess of the 10% threshold, identifying a total of 25 health 
facilities across 6 supported districts (Table 2). All 11 health 
facilities within the district of Pebane exceeded the threshold, 
reporting inadequate levels of Uni-Gold™ between 11.4% 
to 27.3% of the time. The highest frequency was reported 
at the capital health facility, which houses the district-level 
warehouse. It is important to note, however, that the primary 
driver pushing health facilities in Pebane beyond the 10% 
threshold was the high percentage of threatened inventories 
reported, as opposed to reports of stockouts.
A similar pattern was noted within the district of 
Inhassunge. All 5 health facilities in the district exceeded the 
10% threshold of concern, reporting inadequate levels of Uni-
Gold™ ranging between 36.4% and 56.8%. Additionally, it 
was noted that 4 of the 5 facilities (80%) within the district 
of Inhassunge exceeded the 10% threshold when looking at 
complete stockouts alone. 
In contrast to the global patterns of inadequate stock levels 
reported at all health facilities in the other 2 districts in 
which the 10% threshold was breached, namely Pebane and 
Inhassunge, only 4 of 7 (57%) health facilities in the district of 
Namacurra reported inadequate inventory levels, with Uni-
Gold™ exceeding the 10% threshold, ranging between 11.4% 
and 27.3%. The highest of these levels was reported by the 
district capital health facility. 
Patterns Over Time
We further sought to describe adequate test kit inventory 
levels over the 11-month study period. Graphs generated to 
depict the percentage of adequate inventory levels by month 
revealed various degrees of inventory fluctuation within 
each district (Figure 3). Inconsistent inventory levels of the 
Table 1. Categorical Distribution of HIV RDT Inventory Levels Reported in Zambézia Province
(# Health Facilities in District)
(# Weekly Inventory Records)
Good  
No. (%)
Sufficient  
No. (%)
Threatened 
No. (%)
Stockout 
No. (%)
Inadequate*  
No. (%)
Combined sample (n = 75)
Determine™ (3277) 2491 (76.0) 618 (18.9) 164 (5.0) 4 (0.1) 168 (5.1)
Uni-Gold™ (3277) 2139 (65.3) 801 (24.4) 250 (7.6) 87 (2.7) 340 (10.3)
Alto Molocue (n = 12)
Determine™ (528) 347 (65.7) 141 (26.7) 40 (7.6) 0 (0) 40 (7.6)
Uni-Gold™ (528) 319 (60.4) 189 (35.8) 16 (3.0) 4 (0.8) 20 (3.8)
Gilé (n = 8)
Determine™ (336) 301 (89.6) 23 (6.9) 12 (3.6) 0 (0) 12 (3.6)
Uni-Gold™ (336) 275 (81.9) 46 (13.7) 15 (4.5) 0 (0) 15 (4.5)
Inhassunge (n = 5)
Determine™ (220) 17 (7.7) 186 (84.6) 16 (7.3) 1 (0.5) 17 (7.7)
Uni-Gold™ (220) 15 (6.8) 105 (47.7) 67 (30.5) 33 (15) 100 (45.5)
Maganja da Costa (n = 5)
Determine™ (218) 172 (78.9) 43 (19.7) 3 (1.4) 0 (0) 3 (1.4)
Uni-Gold™ (218) 52 (23.9) 152 (69.7) 7 (3.2) 7 (3.2) 14 (6.4)
Mopeia (n = 9)
Determine™ (396) 365 (92.2) 23 (5.8) 8 (2.0) 0 (0) 8 (2.0)
Uni-Gold™ (396) 334 (84.3) 40 (10.1) 21 (5.3) 1 (0.3) 22 (5.5)
Morrumbala (n = 18)
Determine™ (788) 572 (72.6) 154 (19.5) 61 (7.7) 1 (0.1) 62 (7.9)
Uni-Gold™ (788) 649 (82.4) 105 (13.3) 30 (3.8) 4 (0.5) 25 (3.2)
Namacurra (n = 7)
Determine™ (307) 298 (97.1) 3 (1.0) 4 (1.3) 2 (0.7) 6 (2.0)
Uni-Gold™ (307) 183 (59.6) 87 (28.3) 26 (8.5) 11 (3.6) 37 (12.1)
Pebane (n = 11)
Determine™ (484) 419 (86.6) 45 (9.3) 20 (4.1) 0 (0) 20 (4.1)
Uni-Gold™ (484) 312 (64.5) 77 (15.9) 68 (14.1) 27 (5.6) 95 (19.6)
Abbreviation: RDT, rapid diagnostic test.
* Inadequate stock = Threatened Stock + Stockout.
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Determine™ RDT were noted in the districts of Alto Molocue 
and to a lesser extent Morrumbala. However, when compared 
with inventory levels of the Uni-Gold™ test kit, Determine™ 
test kit inventory levels, in the remaining districts, were shown 
to be maintained at consistently high levels throughout the 
study period. Comparatively, adequate inventory levels of the 
Uni-Gold™ test kit were shown to be particularly erratic in 
the districts of Namacurra and Pebane, whereas the district of 
Inhassunge was seen as experiencing persistently inadequate 
levels of Uni-Gold™ throughout the majority of the study 
period.
As these test kits are used sequentially, it is important to 
note the disparity between levels of adequate inventory of the 
2 test kits within a district during a given month. Results from 
the mixed-effect model confirmed the disparity between test 
kit inventories noted above, revealing an 82% higher odds of 
reporting inadequate inventory levels for the Uni-Gold™ test 
kit than for Determine™ (adjusted odds ratio of 1.82, 95% 
CI: 1.40-2.38).
Discussion 
Our evaluation of HIV RDT inventory levels at health facilities 
within Zambézia province, indicate that Determine™ test kits 
were generally well maintained across the majority (ie, >90%) 
of the study sample. Inventory levels of the confirmatory 
Uni-Gold™ test kits, however, told a different tale. When we 
began to closely evaluate stock levels disaggregated by district, 
and then by health facility within districts, we identified stark 
disparities between the inventory levels of the 2 test kits and a 
much higher than anticipated frequency of threatened stocks 
for Uni-Gold™. 
We ultimately identified 3 districts of concern: namely, the 
districts of Pebane, Inhassunge, and Namacurra. Inhassunge 
stood out as a particularly vulnerable district. This was 
especially worrisome as Inhassunge is the district closest to 
Quelimane city, the capital of Zambézia province and the 
location of the provincial warehouse. As such, Inhassunge 
should have sufficient access to, and communication with, 
the provincial warehouse to be able to avoid the high levels of 
stockouts that were reported.
Though missing data is a concern across the sample, the 
district of Gilé stood out as a potential success story. Gilé did 
not report stockouts of either test kit and reported threatened 
inventory levels of less than 5% during the period of evaluation. 
When looking at the proportion of adequate inventory levels 
reported across the facilities of Gilé over time, it is noted that 
the inventory levels of Determine™ and Uni-Gold™ mirror 
each other throughout the study period, suggesting a robust 
Table 2. Inadequate Inventory Levels of the Uni-Gold™ RDT Exceeding the 10% Threshold
District (# Health Facilities) Test Kit Threatened Stockout Inadequate*
Inhassunge (n = 5)
CHF Uni-Gold™ 27.3% 9.1% 36.4%
Bingagira Uni-Gold™ 38.6% 13.6% 52.3%
Chirimane Uni-Gold™ 20.5% 18.2% 38.6%
Gonhane Uni-Gold™ 38.6% 18.2% 56.8%
Palane Mucula Uni-Gold™ 27.3% 15.9% 43.2%
Maganja da Costa (n = 5)
Mbala Uni-Gold™ 2.3% 9.1% 11.4%
Mopeia (n = 9)
CHF Uni-Gold™ 13.6% 0.0% 13.6%
Lua Lua Uni-Gold™ 18.2% 0.0% 18.2%
Morrumbala (n = 18)
DDM Morrumbala Uni-Gold™ 30.2% 9.3% 39.5%
Reis Uni-Gold™ 11.4% 0.0% 11.4%
Namacurra (n = 7)
CHF Uni-Gold™ 18.2% 9.1% 27.3%
Macuse Uni-Gold™ 11.4% 2.3% 13.6%
Mbawa Uni-Gold™ 9.1% 2.3% 11.4%
Muebele Uni-Gold™ 6.8% 6.8% 13.6%
Pebane (n = 11)
CHF Uni-Gold™ 20.5% 6.8% 27.3%
7 de Abril Uni-Gold™ 11.4% 9.1% 20.5%
Alto Maganha Uni-Gold™ 15.9% 6.8% 22.7%
Impaca Uni-Gold™ 11.4% 0.0% 11.4%
Magiga Uni-Gold™ 15.9% 6.8% 22.7%
Malema Uni-Gold™ 13.6% 6.8% 20.4%
Mulela Uni-Gold™ 13.6% 6.8% 20.4%
Muligode Uni-Gold™ 15.9% 0.0% 15.9%
Naburi Uni-Gold™ 13.6% 4.5% 18.1%
Pele Pele Uni-Gold™ 13.6% 6.8% 20.4%
Tomeia Uni-Gold™ 9.1% 6.8% 15.9%
Abbreviations: CHF, Capital Health Facility; RDT, rapid diagnostic test.
* Inadequate stock = Threatened Stock + Stockout.
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and stable forecasting system. As a mid-sized district with 8 
supported health facilities, Gilé warrants further investigation 
into best practices that may be applied to other districts. 
Our study is not the first to document such a disparity 
in RDT inventory levels. An assessment of HIV test kit 
inventories in Tanzania during the early 2000s revealed that 
in health facilities offering HIV testing, often only one type of 
test kit was available.12 More recently, research conducted in 
Ethiopia in 2013 identified increased stockouts of Uni-Gold™ 
as compared to other HIV diagnostic test kits. However, 
as their analysis was more heavily focused on the stocks of 
antiretroviral medications, the authors did not comment as 
to the potential causes of this HIV test kit disparity.28 Lastly, 
an evaluation conducted by the Global Fund to fight AIDS, 
Tuberculosis and Malaria in the Democratic Republic of 
Congo from January 2015 to March 2016, found that the 
average number of days, over the 15-month study period, for 
stockouts of Uni-Gold™ was 59 days compared to just 7 days 
for Determine.29
The specific characteristics of different HIV RDTs, and the 
way they are utilized throughout HIV counseling and testing 
programs, pose particular challenges to forecasting and 
accurately quantifying the number of each test that will be 
required at an individual health facility.11 Though primarily 
limited in focus to the central, regional, and provincial 
(upstream) levels of Mozambique’s supply chain system, 
USAID´s Deliver Project has been working with CMAM, 
providing technical assistance to overcome the many barriers 
that can impact stock quantification exercises. From 2007 
to 2015, significant work went into developing a logistics 
management information system, to improve the quality 
and use of consumption data for forecasting, and in training 
sufficient numbers of personnel on how to proficiently use 
the system.30
As previously described, Mozambique’s supply chain 
system is currently fragmented into 2 distinct arms. The 
portion starting at the provincial warehouses, which supplies 
various districts, and ultimately each individual health facility, 
represents the downstream arm, which is administratively 
Figure 3. Percentage of Adequate Inventory Levels for Each District Over Time. 
* The month of December was removed from the study sample to address 
consistently missing data from all facilities. 
managed through each Provincial Health Directorate. As 
stock levels of the Determine™ test kit were adequately 
maintained throughout the study period and districts, such as 
Gilé, were able to maintain adequate, mirrored levels of both 
HIV RDTs over time, we conclude that the HIV RDT stock 
disparities seen during the study period were not likely due 
to problems in distribution from the provincial warehouse to 
the district warehouses, nor from the district warehouses to 
the individual health facilities. Rather, the low levels of Uni-
Gold™ stock experienced across our study facilities likely 
represents problems in individual health facility forecasting 
of their Uni-Gold™ needs. 
This study has several limitations. This is not a multi-
year study, with analysis limited to an 11-month time 
period. The use of categorical, composite stock data, as 
opposed to individual, raw numbers, inhibited our ability to 
assess inventory levels in relation to stock on hand, test kit 
consumption, and any inventory losses or adjustments that 
may impact forecasting. As of 4 of the 12 supported districts 
were excluded from analysis, due to missing data exceeding 
the study’s inclusion criteria, our findings may not reflect the 
overall HIV RDT inventory status within Zambézia province. 
Additionally, as we did not have inventory data at the 
provincial level, we were unable to rule out the possibility that 
disparities between inventory levels of Determine™ and Uni-
Gold™ test kits were not an artifact of supply chain issues 
occurring further upstream. 
Conclusion
In Mozambique, and beyond, it is important not to forget the 
importance of diagnostic testing. As Test-and-Treat strategies, 
such as the UNAIDS 90-90-90 initiative, continue to scale-up, 
the demand for HIV test kits will only increase, furthering 
the need for adequate forecasting and distribution. Our 
evaluation of 75 health facilities across 8 districts in Zambézia 
province, Mozambique, provided a snapshot of HIV RDT 
inventory status in a geographically rural setting. 
By relying predominantly on composite data, produced 
from the upstream arm of the supply chain, current data 
reporting procedures make it easy for national policy-
makers to interpret downstream inventory levels as being 
satisfactorily maintained. However, by focusing downstream, 
our study identified individual districts and specific health 
facilities exhibiting patterns of test kit inventory levels that 
require further attention, particularly if the goal to halt the 
HIV epidemic is to be achieved. Moving forward, our findings 
point to a need for (1) renewed efforts to reinforce health 
facility forecasting of essential medicines and diagnostic 
tests in general and for Uni-Gold™ test kits specifically, and 
(2) simple metrics that are routinely collected in all health 
facilities and that flow upstream easily and quickly so that 
policy-makers can optimize resource allocations.
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